Management of Hypermagnesemia (Serum Magnesium 5.6 mg/dL)
Immediately discontinue all magnesium-containing medications and supplements, administer IV calcium gluconate 15-30 mL (10%) or calcium chloride 5-10 mL (10%) over 2-5 minutes for cardioprotection, initiate IV fluid hydration with normal saline, and prepare for urgent hemodialysis given the severe elevation and high risk of life-threatening cardiorespiratory complications in this 70-year-old patient.
Immediate Assessment and Stabilization
This magnesium level of 5.6 mg/dL (normal: 1.3-2.2 mEq/L or approximately 1.6-2.6 mg/dL) represents severe hypermagnesemia requiring urgent intervention. At this level, the patient is at imminent risk for:
- Cardiovascular collapse: bradycardia, heart block, cardiac arrhythmias, hypotension, and cardiac arrest 1, 2
- Respiratory failure: hypoventilation progressing to respiratory arrest 2
- Neurological deterioration: altered consciousness, drowsiness progressing to coma, muscular weakness, paralysis 2, 3
Critical Clinical Examination Points
Immediately assess for:
- Vital signs: Look specifically for bradycardia (HR <60), hypotension (SBP <90), and respiratory rate <12
- Cardiac monitoring: Obtain 12-lead ECG looking for prolonged PR interval, widened QRS, heart blocks
- Neurological status: Level of consciousness (GCS), deep tendon reflexes (typically depressed or absent), muscle strength
- Respiratory function: Oxygen saturation, work of breathing, ability to protect airway
Immediate Therapeutic Interventions
1. Calcium Administration (First-Line Cardioprotection)
Administer IV calcium immediately as it directly antagonizes the cardiac and neuromuscular effects of magnesium 1, 2:
- Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes (preferred due to less tissue irritation), OR
- Calcium chloride 10%: 5-10 mL IV over 2-5 minutes (provides more elemental calcium but requires central access)
This provides immediate but temporary cardioprotection while definitive magnesium removal is initiated. The 2020 AHA guidelines specifically recommend calcium for cardiac arrest with known or suspected hypermagnesemia (Class 2b recommendation) 1.
2. Stop All Magnesium Sources
Immediately discontinue:
- Magnesium oxide or other magnesium supplements (most common culprit in elderly patients 4, 5)
- Magnesium-containing antacids or laxatives
- IV magnesium infusions
- Magnesium-containing enemas
Recent case series demonstrate that magnesium oxide, even at standard doses (≤2.0 g daily), can cause severe hypermagnesemia in elderly patients, particularly when combined with any degree of renal impairment 5.
3. Assess Renal Function Urgently
Obtain immediate labs:
- Serum creatinine and calculate eGFR
- BUN
- Electrolytes (calcium, potassium, phosphate)
- Repeat magnesium level
Critical consideration: Hypermagnesemia severe enough to require emergency intervention has been documented even in patients with normal baseline creatinine 5. However, acute kidney injury is present in the majority of severe cases and dramatically impairs magnesium clearance 5.
Definitive Management Strategy
For Patients WITH Normal Renal Function (eGFR >60):
- Aggressive IV hydration: Normal saline at 150-200 mL/hour (adjust for cardiac status)
- Loop diuretics: Furosemide 40-80 mg IV to enhance renal magnesium excretion (only if euvolemic or hypervolemic)
- Monitor magnesium every 4-6 hours until <3.0 mg/dL, then every 12 hours
For Patients WITH Renal Impairment (eGFR <60) or Severe Symptoms:
Urgent hemodialysis is indicated 5, 6:
- Hemodialysis is the most effective method for rapid magnesium removal
- Should be initiated emergently if:
- Magnesium >5.0 mg/dL with cardiac symptoms (bradycardia, hypotension, ECG changes)
- Magnesium >6.0 mg/dL regardless of symptoms
- Respiratory depression or altered mental status at any level
- Renal failure preventing adequate clearance
A 2018 study of patients requiring emergency hemodialysis for hypermagnesemia found median pre-dialysis magnesium of 6.0 mg/dL (range 3.7-18.6), with 14 of 15 patients being elderly (>65 years), and notably, two patients had normal creatinine levels 5.
Ongoing Monitoring
During acute management:
- Continuous cardiac monitoring
- Vital signs every 15-30 minutes initially
- Magnesium levels every 2-4 hours during active treatment
- Calcium levels (as calcium administration can cause hypercalcemia)
- Renal function monitoring
Clinical improvement markers:
- Normalization of heart rate and blood pressure
- Return of deep tendon reflexes
- Improved level of consciousness
- Stable respiratory function
Special Considerations for Elderly Patients
This 70-year-old patient represents the highest-risk demographic. Recent evidence shows 4, 5, 7:
- Age >65 is a major risk factor for severe hypermagnesemia
- Lower body mass correlates with higher magnesium levels
- Subclinical renal impairment may not be apparent from creatinine alone in elderly patients with low muscle mass
- Polypharmacy increases risk (PPIs, diuretics, other medications affecting renal function)
Common Pitfalls to Avoid
- Delaying calcium administration: Do not wait for dialysis availability—give calcium immediately for cardioprotection
- Assuming normal renal function: Even "normal" creatinine may mask significant renal impairment in elderly patients with low muscle mass 5
- Underestimating severity: Magnesium >5.0 mg/dL is a medical emergency requiring ICU-level monitoring
- Inadequate monitoring frequency: Magnesium levels can remain elevated for 24-48 hours even with treatment
- Missing the source: Always review ALL medications including over-the-counter laxatives and antacids
Prognosis and Prevention
With prompt recognition and treatment, most patients recover fully 6. However, delayed treatment can result in fatal cardiac arrest 4. After resolution:
- Avoid all magnesium-containing preparations in patients with any degree of renal impairment
- Monitor renal function regularly if magnesium supplementation is absolutely necessary
- Educate patient and caregivers about avoiding magnesium-containing over-the-counter products